The Netherlands
The Medicines Evaluation Board (MEB) has amended its policy on Direct Healthcare Professional Communications (DHPCs) for medicinal products for human use.
The update includes the following: “The marketing authorisation holder must attach one (or more) photos of the product with the DHPC. The photo is used for better recognition of the relevant product when the DHPC and news item are published.”
Source: https://www.cbg-meb.nl/actueel/nieuws/2020/02/21/aangepast-beleid-dhpcs